Curis (CRIS) Enterprise Value (2010 - 2026)
Curis (CRIS) reported Enterprise Value of -$15.0 million for Q1 2026, up 26.04% on a YoY basis from -$11.9 million in Q1 2025, and down 196.4% quarter-over-quarter from -$5.1 million in Q4 2025.
Curis (CRIS) Enterprise Value (2010 - 2026) Analysis & Trends
Curis has reported Enterprise Value for 17 years, with the latest figure at -$15.0 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 26.04% year-over-year to -$15.0 million; the trailing twelve-month figure through Mar 2026 stood at -$15.0 million (up 26.04% YoY), and the FY2025 full-year result was -$5.1 million, up 74.69% from the prior year.
- Enterprise Value for Q1 2026 stood at -$15.0 million, down from -$5.1 million in the prior quarter.
- The five-year high for Enterprise Value was -$5.1 million in Q4 2025, with the low at -$120.7 million in Q1 2022.
- Historically, Enterprise Value has averaged -$49.5 million across 5 years, with a median of -$40.7 million in 2024.
- Annual changes were most pronounced in 2022 — Enterprise Value climbed 22.86% — and 2025, when it jumped 74.69%.
- Curis' Enterprise Value stood at -$85.6 million in 2022, then surged by 34.21% to -$56.3 million in 2023, then surged by 64.5% to -$20.0 million in 2024, then jumped by 74.69% to -$5.1 million in 2025, then tumbled by 196.4% to -$15.0 million in 2026.
- The last three Enterprise Value figures came in at -$15.0 million (Q1 2026), -$5.1 million (Q4 2025), and -$9.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -584.73 Mn |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | -15.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.00 Mn |
| Dec 31, 2025 | -5.06 Mn |
| Sep 30, 2025 | -9.05 Mn |
| Jun 30, 2025 | -10.14 Mn |
| Mar 31, 2025 | -20.28 Mn |
| Dec 31, 2024 | -20.00 Mn |
| Sep 30, 2024 | -20.85 Mn |
| Jun 30, 2024 | -28.36 Mn |
| Mar 31, 2024 | -40.72 Mn |
| Dec 31, 2023 | -56.33 Mn |
| Sep 30, 2023 | -68.50 Mn |
| Jun 30, 2023 | -63.49 Mn |
| Mar 31, 2023 | -71.76 Mn |
| Dec 31, 2022 | -85.62 Mn |
| Sep 30, 2022 | -98.69 Mn |
| Jun 30, 2022 | -107.20 Mn |
| Mar 31, 2022 | -120.65 Mn |
| Dec 31, 2021 | -115.88 Mn |
| Sep 30, 2021 | -128.90 Mn |
| Jun 30, 2021 | -152.57 Mn |